|
1.Aggarwal BB, Kumar A, Bharti AC. Anticancer. Anticancer potential of curcumin: preclinical and clinical studies. Res. 2003 Jan-Feb;23(1A):363-98. Review. 2.Assuma R, Oates T, Cochran D, Amar S, Graves DT. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimentalperiodontitis. J Immunol. 1998 Jan 1;160(1):403-9. 3.Bhawana, Basniwal RK, Buttar HS, Jain V, Jain N. Curcumin nanoparticles: preparation, characterization, and antimicrobial study. J Aqric Food Chem 2011;59:2056-61. 4.Cai, X., Li, C., Du, G. & Cao, Z. Protective effects of baicalin on ligature-induced periodontitis in rats. J Periodontal Res 2008;43:14-21. 5.Chen D, Nie M, Fan MW, Bian Z. Anti-inflammatory activity of curcumin in macrophages stimulated by lipopolysaccharides from Porphyromonas gingivalis. Pharmacology. 2008;82(4):264-9. 6.Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol. 2008 Aug;79(8 Suppl):1569-76. 7.Eigner D, Scholz D. Ferula asa-foetida and Curcuma longa in traditional medical treatment and diet in Nepal. J Ethnopharmacol. 1999 Oct;67(1):1-6. 8.Gray, K. A., Farchaus, J. W., Wachtveitl, J., Breton, J. & Oesterhelt, D. Initial characterization of site-directed mutants of tyrosine M210 in the reaction centre of Rhodobacter sphaeroides. EMBO 1990;J 9:2061-70. 9.Gu Y, Lee HM, Napolitano N, Clemens M, Zhang Y, Sorsa T, Zhang Y, Johnson F, Golub LM. 4-methoxycarbonyl curcumin: a unique inhibitor of both inflammatory mediators and periodontal inflammation. Mediators Inflamm. 2013;2013:329740. 10.Guimaraes MR, Coimbra LS, de Aquino SG, Spolidorio LC, iekkwood KL, Junior CR. Potent anti-inflammatory effects of systemically-administered curcumin modulates periodontal disease in vivo. J Periodontal Res 2011;46(2):269-29. 11.Gustafsson A, Asman B. Increased release of free oxygen radicals from peripheral neutrophils in adult periodontitis after Fc delta-receptor stimulation. J Clin Periodontol. 1996 Jan;23(1):38-44. 12.Helming, L. & Gordon, S. Molecular mediators of macrophage fusion. Trends Cell Biol 2009;19:514-22. 13.Hu P, Huang P, Chen MW. Curcumin attenuates cyclooxygenase-2 expression via inhibition of the NF-κB pathway in lipopolysaccharide-stimulated human gingival fibroblasts. Cell Biol Int. 2013 May;37(5):443-8. 14.Hussan F, Ibraheem NG, Kamarudin TA, Shuid AN, Soelaiman IN, Othman F. Curcumin Protects Against Overiectomy-Induced Bone Changes in Rat Model. Evid Based Complement Alternat Med. 2012;2012:174916. 15.Joe B, Vijaykumar M, Lokesh BR. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr. 2004;44(2):97-111. 16.Kukita, T. & Kukita, A. Osteoclast differentiation antigen. Histol Histopathol 1996;11:821-30. 17.Lacey, D. L., Tan, H. L., Lu, J., Kaufman, S., Van, G., Qiu, W., Rattan, A., Scully, S., Fletcher, F., Juan, T., Kelley, M., Burgess, T. L., Boyle, W. J. & Polverino, A. J. Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol 2000;157:435-48. 18.Lerner UH. Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. J Dent Res. 2006 Jul;85(7):596-607. 19.Lu SH, Huang RY, and Chou TC. Magnolol Ameliorates Ligature-Induced Periodontitis in Rats and Osteoclastogenesis: In Vivo and In Vitro Study. Evid Based Complement Alternat Med. 2013;2013:634095. 20.Reinholt, F. P., Hultenby, K., Heinegard, D., Marks, S. C., Jr., Norgard, M. & Anderson, G. Extensive clear zone and defective ruffled border formation in osteoclasts of osteopetrotic (ia/ia) rats: implications for secretory function. Exp Cell Res 1999;251:477-91. 21.Riggs, B. L. & Khosla, S. Role of biochemical markers in assessment of osteoporosis. Acta Orthop Scand Suppl 1995;266:14-8. 22.Shalhoub, V., Faust, J., Boyle, W. J., Dunstan, C. R., Kelley, M., Kaufman, S., Scully, S., Van, G. & Lacey, D. L. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. J Cell Biochem 1999;72:251-61. 23.Taubman MA, Haffajee AD, Socransky SS, Smith DJ, Ebersole JL. Longitudinal monitoring of humoral antibody in subjects with destructive periodontal diseases. J Periodontal Res. 1992 Sep;27(5):511-21. 24.Wahl, L. M. & Corcoran, M. L. Regulation of monocyte/macrophage metalloproteinase production by cytokines. J Periodontol 1993;64:467-73. 25.Yamalik N, Cağlayan F, Kilinç K, Kilinç A, Tümer C. The importance of data presentation regarding gingival crevicular fluid myeloperoxidase and elastase-like activity in periodontal disease and health status. J Periodontol. 2000 Mar;71(3):460-7. 26.Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N. & Suda, T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 1998;95:3597-602. 27.Ying Gu, Hsi-Ming Lee, Nicole Napolitano, McKenzie Clemens, Yazhou Zhang, Timo Sorsa, Yu Zhang, Francis Johnson, and Lorne M. Golub. 4-Methoxycarbonyl Curcumin: A Unique Inhibitor of Both Inflammatory Mediators and Periodontal Inflammation. Mediators of Inflammation Volume 2013, Article ID 329740, 10 pages. 28.Zhou T, Chen D, Li Q, Sun X, Song Y, Wang C. Curcumin inhibits inflammatory response and bone loss during experimental periodontitis in rats. Acta Odontol Scand. 2013 Mar;71(2):349-56.
|